Loading…
T ‐bet is a new synergistic meeting point for the BCR and TLR 9 signaling cascades
The importance of the BCR and TLR 9 in autoimmunity and in the production of auto‐antibodies is well established but the underlying molecular mechanism still needs to be determined. Here, we aim to characterize the BCR ‐ TLR 9 cross‐talk by its effect on T ‐bet, as T ‐bet is activated and regulated...
Saved in:
Published in: | European journal of immunology 2014-03, Vol.44 (3), p.887-893 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The importance of the
BCR
and
TLR
9 in autoimmunity and in the production of auto‐antibodies is well established but the underlying molecular mechanism still needs to be determined. Here, we aim to characterize the
BCR
‐
TLR
9 cross‐talk by its effect on
T
‐bet, as
T
‐bet is activated and regulated by both receptors and has an important role in class‐switching to pathological
I
g
G
2a in mice. Using primary mouse
B
cells, we demonstrate that
T
‐bet expression is synergistically elevated by the cross‐talk between the
BCR
and
TLR
9. To test the effect of this synergy on
I
g
G
2a‐switching, the levels of switched
B
cells were checked by functional tests. We found that
BCR
costimulation had no additional effect on
TLR
9‐induced
I
g
G
2a expression, however the expression of
R
ad51 was synergistically increased. To check the biological significance of the synergy, we compared
T
‐bet expression in
B
cells from healthy and collagen‐induced arthritis mice but no differences were found. Taken together, we demonstrate here that signaling cascades driven by the
BCR
and
TLR
9 have a newly identified meeting point at
T
‐bet. The two cascades act synergistically on
T
‐bet; however additional signals may be needed to induce prolonged functional responses such as class‐switch recombination. |
---|---|
ISSN: | 0014-2980 1521-4141 |
DOI: | 10.1002/eji.201343841 |